Abstract
The development of neuroimaging methods allows to obtain new data on the brain functioning to find neuroimaging patterns of psychopathological conditions, creating a basis for further application of neuroscience research results in practical medicine. The involvement of insulin-like growth factor 1 (IGF1), which has a wide range of biological functions that include stimulation of glucose metabolism and transport, stimulation of cell proliferation and differentiation, inhibition of cell apoptosis and immune process regulation, is of great interest in the pathogenesis of schizophrenia.
The aim of the work was to study possible associations of structural brain changes according to fMRI data with a multifunctional growth factor, IGF1, and systemic inflammatory immunity parameters for multilateral assessment of the state of neuro-immune interrelations in schizophrenia.
52 schizophrenic patients and 67 healthy volunteers were enrolled into the study. An interdisciplinary approach was used, including psychological testing (clinical method), neurophysiological and immunological testing, and cross-methodological calculations.
Patients with decreased IGF-1 levels had the reduced average cortical thickness in a number of cortical areas in the left and right hemisphere. Patients with low IGF1 levels had higher systemic inflammation and signs of autoimmune reactions. Assessment of association of IGF-1 levels with clinical symptoms has shown that decreased IGF-1 levels were associated with motor disorders.
The results show that the level of IGF1 growth factor reflects the features of immune-inflammatory disorders, the severity of brain morphometric disorders and extrapyramidal disorders in patients with schizophrenia. The identified associations show the presence and significance of impaired neuroimmune interactions in schizophrenia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Millan, M.J., et al.: Altering the course of schizophrenia: progress and perspectives. Nat. Rev. Drug Disc. 15(7), 485–515 (2016)
Lu, X.B., et al.: Analysis of first-episode and chronic schizophrenia using multi-modal magnetic resonance imaging. Eur. Rev. Med. Pharmacol. Sci. 22(19), 6422–6435 (2018)
Wojtalik, J.A., Smith, M.J., Keshavan, M.S., Eack, S.M.: A systematic and meta-analytic review of neural correlates of functional outcome in schizophrenia. Schizophr. Bull. 43(6), 1329–1347 (2017)
Liloia, D., et al.: Updating and characterizing neuroanatomical markers in high-risk subjects, recently diagnosed and chronic patients with schizophrenia: a revised coordinate-based meta-analysis. Neurosci. Biobehav. Rev. 123, 83–103 (2021)
Goldsmith, D.R., Rapaport, M.H., Miller, B.J.: A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol. Psychiatry 21(12), 1696–1709 (2016)
Miller, B.J., Buckley, P., Seabolt, W., Mellor, A., Kirkpatrick, B.: Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 70(7), 663–671 (2011)
Potvin, S., Stip, E., Sepehry, A.A., Gendron, A., Bah, R., Kouassi, E.: Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol. Psychiatry 63(8), 801–808 (2008)
Ruzzo, E.K., Geschwind, D.H.: Schizophrenia genetics complements its mechanistic understanding. Nat. Neurosci. 19(4), 523–525 (2016)
Schafer, D.P., et al.: Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74(4), 691–705 (2012)
Sekar, A., et al.: Schizophrenia risk from complex variation of complement component. Nature 530(7589), 177–183 (2016)
Labandeira-Garcia, J.L., Costa-Besada, M.A., Labandeira, C.M., Villar-Cheda, B., Rodríguez-Perez, A.I.: Insulin-like growth factor-1 and neuroinflammation. Front. Aging Neurosci. 9, 365 (2017)
Okamoto, N., et al.: Association between serum insulin-like growth factor 1 levels and the clinical symptoms of chronic schizophrenia: preliminary findings. Front. Psych. 12, 653802 (2021)
Isobe, M., Miyata, J., Hazama, M., Fukuyama, H., Murai, T., Takahashi, H.: Multimodal neuroimaging as a window into the pathological physiology of schizophrenia: Current trends and issues. Neurosci. Res. 102, 29–38 (2016)
Iliuta, F.P., Manea, M.C., Budisteanu, M., Ciobanu, A.M., Manea, M.: Magnetic resonance imaging in schizophrenia: luxury or necessity? (Review). Exp. Ther. Med. 22(1), 765 (2021)
Walton, E., et al.: Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium. Psychol. Med. 48(1), 82–94 (2018)
Godwin, D., Alpert, K.I., Wang, L., Mamah, D.: Regional cortical thinning in young adults with schizophrenia but not psychotic or non-psychotic bipolar I disorder. Int. J. Bipolar Disord. 6(1), 1–13 (2018). https://doi.org/10.1186/s40345-018-0124-x
Zhuo, C., et al.: Strategies to solve the reverse inference fallacy in future MRI studies of schizophrenia: a review. Brain Imaging Behav. 15(2), 1115–1133 (2020). https://doi.org/10.1007/s11682-020-00284-9
Kochunov, P., Thompson, P.M., Hong, L.E.: Toward high reproducibility and accountable heterogeneity in schizophrenia research. JAMA Psychiatry 76(7), 680–681 (2019)
Rogers, J.P., Pollak, T.A., Blackman, G., David, A.S.: Catatonia and the immune system: a review. Lancet Psychiatry 6(7), 620–630 (2019)
Fernandez, A.M., Torres-Aleman, I.: The many faces of insulin-like peptide signalling in the brain. Nat. Rev. Neurosci 13(4), 225–239 (2012)
Liu, H.C., Leu, S.J., Chuang, D.M.: Roles of glycogen synthase kinase-3 in Alzheimer’s disease: from pathology to treatment target. J. Exp. Clin. Med. 4(3), 135–139 (2012)
Ge, R.T., Mo, L.H., Wu, R., et al.: Insulin-like growth factor-1 endues monocytes with immune suppressive ability to inhibit inflammation in the intestine. Sci. Rep 5, 1–7 (2015)
Yuan, T., et al.: The role of serum growth hormone and insulin-like growth factor-1 in adult humans brain morphology. Aging (Albany NY) 12(2), 1377–1396 (2020)
Yang, H., et al.: Alterations in cortical thickness in young male patients with childhood-onset adult growth hormone deficiency: a morphometric MRI study. Front. Neurosci. 13, 1134 (2019)
Chao, X.L., et al.: The association between serum insulin-like growth factor 1 and cognitive impairments in patients with schizophrenia. Psychiatry Res 285, 112731 (2020)
Acknowledgements
This work was supported by NRC “Kurchatov Institute” (article 1.8 of Thematic Plan; R&D “Biomedical Technologies”, subtopic 10 “Immunogenetic strategies for the diagnosis and treatment of schizophrenia”, order No. 2757 of October 28, 2021), and partially by RSF (grant 20-15-00299), by the grant by the Ministry of Science and Higher Education of the Russian Federation (Grant 075-15-2020-801), by the grant by the Ministry of Science and Higher Education of the Russian Federation (Grant 0723-2020-0036).
.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Malashenkova, I.K. et al. (2023). Associations of Morphometric Changes of the Brain with the Levels of IGF1, a Multifunctional Growth Factor, and with Systemic Immune Parameters Reflect the Disturbances of Neuroimmune Interactions in Patients with Schizophrenia. In: Kryzhanovsky, B., Dunin-Barkowski, W., Redko, V., Tiumentsev, Y. (eds) Advances in Neural Computation, Machine Learning, and Cognitive Research VI. NEUROINFORMATICS 2022. Studies in Computational Intelligence, vol 1064. Springer, Cham. https://doi.org/10.1007/978-3-031-19032-2_17
Download citation
DOI: https://doi.org/10.1007/978-3-031-19032-2_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-19031-5
Online ISBN: 978-3-031-19032-2
eBook Packages: Intelligent Technologies and RoboticsIntelligent Technologies and Robotics (R0)